These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 17251983)

  • 21. Safeguarding against substandard/counterfeit drugs: mitigating a macroeconomic pandemic.
    Wertheimer AI; Norris J
    Res Social Adm Pharm; 2009 Mar; 5(1):4-16. PubMed ID: 19285285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The morally uncomfortable global drug gap.
    Cohen-Kohler JC
    Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices.
    Moken MC
    Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247
    [No Abstract]   [Full Text] [Related]  

  • 25. Policy implications of drug importation.
    Palumbo FB; Mullins CD; Slagle AF; Rizer J
    Clin Ther; 2007 Dec; 29(12):2758-67. PubMed ID: 18201594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Gateway Paper--context and configuration of the proposed health reforms in Pakistan.
    Nishtar S
    J Pak Med Assoc; 2006 Dec; 56(12 Suppl 4):S2-13. PubMed ID: 17595829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quality of medicines in least developed countries].
    Videau JY
    Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug access in poor countries].
    Sebbag R
    Bull Acad Natl Med; 2007 Nov; 191(8):1601-2. PubMed ID: 18666459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How can states provide affordable pharmaceuticals to the underserved?
    Zara J
    J Health Care Poor Underserved; 2006 Nov; 17(4):808-20. PubMed ID: 17242532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Providing affordable essential medicines to African households: the missing policies and institutions for price containment.
    Tetteh Ek
    Soc Sci Med; 2008 Feb; 66(3):569-81. PubMed ID: 18023953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of online pharmacy: an Australian perspective.
    Bernath P
    J Law Med; 2003 Feb; 10(3):339-63. PubMed ID: 12650004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-year assessment of joint procurement of pharmaceuticals in the public health sector in Jordan.
    Al-Abbadi I; Qawwas A; Jaafreh M; Abosamen T; Saket M
    Clin Ther; 2009 Jun; 31(6):1335-44. PubMed ID: 19695398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Funding pharmaceutical innovation through direct tax credits.
    Lybecker KM; Freeman RA
    Health Econ Policy Law; 2007 Jul; 2(Pt 3):267-84. PubMed ID: 18634650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Essential drugs and registration of pharmaceuticals: the Sri Lankan experience.
    Weerasuriya K
    Bull World Health Organ; 1993; 71(2):229-35. PubMed ID: 8490987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National transparency assessment of Kuwait's pharmaceutical sector.
    Badawi DA; Alkhamis Y; Qaddoumi M; Behbehani K
    Health Policy; 2015 Sep; 119(9):1275-83. PubMed ID: 26229022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beef up international cooperation on counterfeits.
    Shepherd M
    Nat Med; 2010 Apr; 16(4):366. PubMed ID: 20376036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of corruption in the health sector: theory, methods and interventions.
    Vian T
    Health Policy Plan; 2008 Mar; 23(2):83-94. PubMed ID: 18281310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Counterfeit and substandard antimalarial drugs in Cambodia.
    Lon CT; Tsuyuoka R; Phanouvong S; Nivanna N; Socheat D; Sokhan C; Blum N; Christophel EM; Smine A
    Trans R Soc Trop Med Hyg; 2006 Nov; 100(11):1019-24. PubMed ID: 16765399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.